Skip to main content
Contact Us
Subscribe
E-Edition
80°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Avinger Inc
(NQ:
AVGR
)
1.420
-0.190 (-11.80%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Jul 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Avinger Inc
< Previous
1
2
3
Next >
Ground-Breaking Clinical Data from INSIGHT Trial Presented at VIVA
October 07, 2021
Study Outcomes Demonstrate Safety and Efficacy of Pantheris for Treatment of In-Stent Restenosis REDWOOD CITY, CA / ACCESSWIRE / October 7, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage...
From
Avinger, Inc.
Via
AccessWire
Exposures
Product Safety
Avinger To Present at the H.C. Wainwright 23rd Annual Global Investment Conference September 13-15
September 08, 2021
REDWOOD CITY, CA / ACCESSWIRE / September 8, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system...
From
Avinger, Inc.
Via
AccessWire
Avinger OCT-Guided Technologies Featured at AMP 2021
August 16, 2021
REDWOOD CITY, CA / ACCESSWIRE / August 16, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system...
From
Avinger, Inc.
Via
AccessWire
Avinger Reports Second Quarter 2021 Financial Results
August 10, 2021
Pantheris Sales and Tigereye™ Expansion Drive 91% Year-Over-Year Revenue Growth REDWOOD CITY, CA / ACCESSWIRE / August 10, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company...
From
Avinger, Inc.
Via
AccessWire
Exposures
COVID-19
Product Safety
Avinger Announces 510(k) Filing for New Lightbox 3 Imaging Console
August 09, 2021
Smaller Footprint, Improved User Experience and Lower Cost to Drive Adoption REDWOOD CITY, CA / ACCESSWIRE / August 9, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company...
From
Avinger, Inc.
Via
AccessWire
Avinger to Announce Second Quarter 2021 Results on August 10, 2021
July 27, 2021
REDWOOD CITY, CA / ACCESSWIRE / July 27, 2021 / Avinger, Inc. (Nasdaq:AVGR), commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for...
From
Avinger, Inc.
Via
AccessWire
Avinger Announces 510(k) Filing for New Pantheris In-Stent Restenosis Indication
July 06, 2021
REDWOOD CITY, CA / ACCESSWIRE / July 6, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for...
From
Avinger, Inc.
Via
AccessWire
Exposures
Product Safety
Avinger Announces Key Opinion Leader Presentations at Vascular Conferences in Germany
June 28, 2021
REDWOOD CITY, CA / ACCESSWIRE / June 28, 2021 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for...
From
Avinger, Inc.
Via
AccessWire
Avinger Announces Presentations by Key Opinion Leaders at New Cardiovascular Horizons Annual Conference
June 07, 2021
REDWOOD CITY, CA / ACCESSWIRE / June 7, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for...
From
Avinger, Inc.
Via
AccessWire
Avinger Announces Issuance and Allowance of Seven U.S. Patents
May 25, 2021
REDWOOD CITY, CA / ACCESSWIRE / May 25, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for...
From
Avinger, Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Avinger To Present at the Oppenheimer MedTech, Tools & Diagnostics Summit May 26
May 17, 2021
REDWOOD CITY, CA / ACCESSWIRE / May 17, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for...
From
Avinger, Inc.
Via
AccessWire
Avinger Reports First Quarter 2021 Financial Results
May 06, 2021
13% Year-over-Year Revenue Growth Driven by Tigereye™ Commercial Launch and Pantheris SV Sales Growth REDWOOD CITY, CA / ACCESSWIRE / May 6, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage...
From
Avinger, Inc.
Via
AccessWire
Exposures
COVID-19
Avinger to Announce First Quarter 2021 Results on May 6, 2021
April 26, 2021
REDWOOD CITY, CA / ACCESSWIRE / April 26, 2021 / Avinger, Inc. (NASDAQ:AVGR), commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for...
From
Avinger, Inc.
Via
AccessWire
New Publications Highlight Clinical Benefits of Avinger PAD Therapies
April 21, 2021
REDWOOD CITY, CA / ACCESSWIRE / April 21, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system...
From
Avinger, Inc.
Via
AccessWire
Avinger Achieves Commercial Milestone with More Than 100 Accounts Using Pantheris SV
April 15, 2021
REDWOOD CITY, CA / ACCESSWIRE / April 15, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system...
From
Avinger, Inc.
Via
AccessWire
Clinical Trials Critical for the Evaluation of Advanced Medical Imaging Tools
April 14, 2021
Via
FinancialNewsMedia
Avinger Provides Update on Tigereye(TM) Commercial Launch
April 08, 2021
REDWOOD CITY, CA / ACCESSWIRE / April 8, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for...
From
Avinger, Inc.
Via
AccessWire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.